Drawing for CIRCUIT CLINICAL

USPTO serial 87657541

CIRCUIT CLINICAL

Reviewed by CopyMark Law Group

Reg. 5829505Status 702Registered
Filing date
Status date
Registration date
Aug 6, 2019
Examiner
KETCHUM, BRENDAN J
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with CIRCUIT CLINICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura W. Smalley, Esq.

Laura W. Smalley, Esq. Harris Beach Murtha Cullina PLLC99 Garnsey RoadPittsford, NY 14534United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting services, namely, consulting in the field of medical clinical trials management; Interactive record-keeping services for use in regulatory compliance in clinical trials by professionals in the medical field; Business services provided in the field of clinical trials management, namely, data collection services for business purposes in the nature of extracting, summarizing, analyzing and validating information from medical records; Business data compilation and tracking services for others, namely, interactive tracking of clinical trial subject enrollment, status and adverse/side effects of treatment and medication, including interactive services on mobile platformACTIVENov 12, 2018
042Consulting services for others in the field of medical clinical trials, namely, consultation on conducting medical clinical trials; Medical automation services, namely, providing point-of-contact electronic data capture of patient visits for clinical trials; Interactive medical clinical trial monitoring and alerts, namely, services for reminding clients of clinical trial parameters, treatment protocols, medicinal dosage, and prescription refills for clinical trial purposes; Medical clinical trial information services, namely, services featuring reminder alerts regarding clinical trial appointments scheduled for participants in clinical trials, and reporting of consumer authorized clinical testing results directly to the clinical trial participantACTIVENov 12, 2018
044Medical care and treatment consulting services in the field of medical clinical trials; Medical clinical trial assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of archived medical images and a data storage and retrieval system; Medical care monitoring of clinical trial patients; Medical reporting services for clinical trials; Providing an on-line, patient-initiated, patient-authorized, medical profile and medical record analysis service designed to provide clinical trial subjects with custom-tailored information and education about medical treatment and therapies associated with their medical conditions; Providing medical information, consultancy and advisory services; Emergency response medical alarm monitoring services for subjects enrolled in clinical trialsACTIVENov 12, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 6, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Nov 6, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Nov 6, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 15, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Aug 6, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 13, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 27, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 27, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 27, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 27, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 6, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 3, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 2, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 11, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 4, 2019IUAFUSE AMENDMENT FILED—
Jun 4, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 22, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 20, 2018EX1GSOU EXTENSION 1 GRANTED—
Nov 20, 2018EXT1SOU EXTENSION 1 FILED—
Nov 20, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 5, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 5, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 19, 2018EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 5, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 10, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 10, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 21, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 6, 2018EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 5, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 27, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Feb 27, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 27, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 27, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 7, 2018UNDCUNDELIVERABLE MAIL - COURTESY COPY MAILED—
Feb 5, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 2, 2018DOCKASSIGNED TO EXAMINER—
Nov 2, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 27, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance